| Peer-Reviewed

The Excellence of Pharmacy Service: Past, Present and Future

Received: 14 February 2019     Accepted: 10 April 2019     Published: 25 December 2019
Views:       Downloads:
Abstract

Pharmacy education continues to evolve to better prepare pharmacists for their roles and responsibilities in an increasingly complex health care environment with advanced patient health needs. Another important factor is the pharmacists themselves. Over the past 50 years, the role of pharmacists has evolved along with the health care needs of our population. In addition to dispensing medications and ensuring patient safety, today’s pharmacists are taking a larger role as medical counselors, educators and advocates. They are integral part of the health care team, and are among the most trusted and accessible health care professionals. This accessibility allows them to perform more patient care activities, including counseling, medication management, and preventive care screenings. Beyond the care provided to individual patients, pharmacists have expanded their reach to influence the public health of communities. A pharmacist is uniquely positioned to provide disease state management through appropriate medication therapy management that has been demonstrated to improve patient outcomes and decrease overall health care costs. This role is more important than ever as the environment is demanding new practice and payment models that are required to further optimize care and outcomes while addressing the unsustainable increases in health care costs. All people who take medications are at risk of actual or potential drug therapy problems. These problems are a significant source of morbidity and mortality when left undetected and unresolved and drive huge costs across the health system. As drug therapy experts, pharmacists provide drug therapy management services built around a partnership between the pharmacist, the patient (or his or her caregiver), physicians and other members of a patient’s health care team.

Published in International Journal of Clinical and Developmental Anatomy (Volume 5, Issue 2)
DOI 10.11648/j.ijcda.20190502.12
Page(s) 11-32
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2019. Published by Science Publishing Group

Keywords

HMO, Patient Compliance, Medication Adherence, Pharmacy Profession, Medicine

References
[1] APhA. Principles of Practice for Pharmaceutical Care. Available From: https://www.pharmacist.com/principles-practice-pharmaceutical-care
[2] Jaiprakash V. Kokan, Pawan S. Avhad Role of Pharmacist in Health Care System The Journal of Community Health Management, January-March 2016; 3 (1): 37-40.
[3] Stephanie Y. Crawford Pharmacists’ Roles in Health Promotion and Disease Prevention American Journal of Pharmaceutical Education 2005; 69 (4) Article 73.
[4] Ferreri SP, Cross LB, Hanes SD, Jenkins T, Meyer D, Pittenger A. Academic Pharmacy: Where is Our Influence?. Am J Pharm Educ. 2017; 81 (4): 63.
[5] Page E. How pharmacists can start a career in the pharmaceutical industry. The Pharmaceutical Journal 9 MAR 2015.
[6] Flink JL. Chapter 1. Scope of Pharmacy. In: Remington: The Science and Practice Of Pharmacy. Author: Joseph P Remington; Paul Beringer Publisher: Philadelphia: Lippincott Williams & Wilkins, 2006.
[7] Atkinson J, De Paepe K, Pozo AS, et al. A Study on How Industrial Pharmacists Rank Competences for Pharmacy Practice: A Case for Industrial Pharmacy Specialization. Pharmacy (Basel). 2016; 4 (1): 13. Published 2016 Feb 6. doi: 10.3390/pharmacy4010013.
[8] Chisholm-Burns MA, Gatwood J, Spivey CA. Economic Analysis of Obtaining a PharmD Degree and Career as a Pharmacist. Am J Pharm Educ. 2015; 79 (8): 117.
[9] Brazeau GA, Meyer SM, Belsey M, et al. Preparing pharmacy graduates for traditional and emerging career opportunities. Am J Pharm Educ. 2009; 73 (8): 157.
[10] Rossheim J. Diverse Opportunities Await Pharmacists in Industry. Available From: https://www.monster.com/career-advice/article/pharma-industry-jobs-for-pharmacists
[11] Wiedenmayer K, Summers RS, Mackie CA and others. Developing pharmacy practice A focus on patient care HANDBOOK – 2006 EDITION. Available From: http://apps.who.int/iris/bitstream/handle/10665/69399/?sequence=1
[12] The Health Promotion Strategic Framework. Available From: https://www.healthpromotion.ie/hp-files/docs/HPSF_HSE.pdf
[13] Tseng A, Foisy M, Hughes CA, et al. Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines. Can J Hosp Pharm. 2012; 65 (2): 125-45.
[14] NICE. Contraceptive services for under 25s. Public health guideline Published: 26 March 2014.
[15] Tong S, Amand C, Kieffer A, Kyaw MH. Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008-2014. BMC Health Serv Res. 2018; 18 (1): 715. Published 2018 Sep 14. doi: 10.1186/s12913-018-3529-4.
[16] Katoue MG. Role of pharmacists in providing parenteral nutrition support: current insights and future directions. Integr Pharm Res Pract. 2018; 7: 125-140. Published 2018 Oct 2. doi: 10.2147/IPRP. S117118.
[17] Gelayee DA, Mekonnen GB. Pharmacy students' provision of health promotion counseling services during a community pharmacy clerkship: a cross sectional study, Northwest Ethiopia. BMC Med Educ. 2018; 18 (1): 95. Published 2018 May 4. doi: 10.1186/s12909-018-1216-0.
[18] Saxena P, Mishra A, Nigam A. Evaluation of Pharmacists' Services for Dispensing Emergency Contraceptive Pills in Delhi, India: A Mystery Shopper Study. Indian J Community Med. 2016; 41 (3): 198-202.
[19] Chin-Quee DS, Stanback J, Orr T. Family planning provision in pharmacies and drug shops: an urgent prescription. Contraception. 2018 Nov; 98 (5): 379-382. doi: 10.1016/j. contraception. 2018. 08. 013. Epub 2018 Aug 28. PubMed PMID: 30170029.
[20] Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2012; 35 (12): 2706-17.
[21] FIP. Pharmacists supporting Women and responsible use of medicines. Empowering informal caregivers 2018. Available From: https://www.fip.org/files/fip/publications/Pharmacists-supporting-women-responsible-use-medicines. pdf
[22] Toklu HZ, Hussain A. The changing face of pharmacy practice and the need for a new model of pharmacy education. J Young Pharm. 2013; 5 (2): 38-40.
[23] Ali A, Katz DL. Disease Prevention and Health Promotion: How Integrative Medicine Fits. Am J Prev Med. 2015; 49 (5 Suppl 3): S230-40.
[24] Institute for Work & Health (Toronto). What researchers mean by Primary, secondary and tertiary prevention. Published: April 2015.
[25] National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on Community-Based Solutions to Promote Health Equity in the United States; Baciu A, Negussie Y, Geller A, et al., editors. Communities in Action: Pathways to Health Equity. Washington (DC): National Academies Press (US); 2017 Jan 11. 8, Community Tools to Promote Health Equity.
[26] Pharmacy Board of Australia. Guidelines for dispensing of medicines. Available From: http://apps.who.int/medicinedocs/en/m/abstract/Js17807en/
[27] Management Sciences for health (2012). chapter 30. Ensuring good dispensing practices. Available From: http://apps.who.int/medicinedocs/documents/s19607en/s19607en.pdf
[28] Management Sciences for health (2012). chapter 45. Hospital pharmacy management. Available From: http://apps.who.int/medicinedocs/documents/s19622en/s19622en.pdf
[29] Warner DJ (ASHP). The Clinical Pharmacists’ Role in Patient Safety. Available From: https://www.hamad.qa/EN/All-Events/CPC/Program/Documents/David-Warner-Plenary1.pdf
[30] FIP. Revised Fip Basel Statements On The Future Of Hospital Pharmacy. Approved September 2014, Bangkok, Thailand, as revisions of the initial 2008 version.
[31] Goundrey-Smith S. The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy. Front Pharmacol. 2018; 9: 1352. Published 2018 Nov 28. doi: 10.3389/fphar. 2018. 01352.
[32] Schwartzberg E, Nathan JP, Avron S, Marom E. Clinical and other specialty services offered by pharmacists in the community: the international arena and Israel. Isr J Health Policy Res. 2018; 7 (1): 59. Published 2018 Dec 1. doi: 10.1186/s13584-018-0251-y.
[33] Scott DM. United States Health Care System: A Pharmacy Perspective. Can J Hosp Pharm. 2016; 69 (4): 306-15.
[34] Hermansyah A, Sainsbury E, Krass I. Multiple policy approaches in improving community pharmacy practice: the case in Indonesia. BMC Health Serv Res. 2018; 18 (1): 449. Published 2018 Jun 14. doi: 10.1186/s12913-018-3258-8.
[35] Barber N, Smith F, Anderson S. Improving quality of health care: the role of pharmacists. Improving quality of health care: the role of pharmacists Quality in Health Care 1994; 3: 153-158.
[36] Mahmoodpoor A, Kalami A, Shadvar K, Entezari-Maleki T, Hamishehkar H. Evaluation of Clinical Pharmacy Services in the Intensive Care Unit of a Tertiary University Hospital in the Northwest of Iran. J Res Pharm Pract. 2018; 7 (1): 30-35.
[37] Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017; 6: 37-46. Published 2017 Jan 25. doi: 10.2147/IPRP. S108047.
[38] Lampkin SJ, Gildon B, Benavides S, Walls K, Briars L. Considerations for Providing Ambulatory Pharmacy Services for Pediatric Patients. J Pediatr Pharmacol Ther. 2018; 23 (1): 4-17.
[39] de Barra M, Scott CL, Scott NW, Johnston M, de Bruin M, Nkansah N, Bond CM, Matheson CI, Rackow P, Williams AJ, Watson MC. Pharmacist services for non-hospitalised patients. Cochrane Database Syst Rev. 2018 Sep 4; 9: CD013102. doi: 10.1002/14651858. CD013102. Review. PubMed PMID: 30178872.
[40] Hawes EM, Misita C, Burkhart JI, McKnight L, Deyo ZM, Lee RA, Howard C, Eckel SF. Prescribing pharmacists in the ambulatory care setting: Experience at the University of North Carolina Medical Center. Am J Health Syst Pharm. 2016 Sep 15; 73 (18): 1425-33. doi: 10.2146/ajhp150771. PubMed PMID: 27605321.
[41] de Sousa IC, de Lima David JP, Noblat Lde A. A drug information center module to train pharmacy students in evidence-based practice. Am J Pharm Educ. 2013; 77 (4): 80.
[42] Alamri SA, Ali Al Jaizani R, Naqvi AA, Ghamdi MSA. Assessment of Drug Information Service in Public and Private Sector Tertiary Care Hospitals in the Eastern Province of Saudi Arabia. Pharmacy (Basel). 2017; 5 (3): 37. Published 2017 Jul 4. doi: 10.3390/pharmacy5030037.
[43] WHO web. The Role of the Pharmacist in the Health-Care System - Preparing the Future Pharmacist: Curricular Development, Report of a Third WHO Consultative Group on the Role of the Pharmacist Vancouver, Canada, 27-29 August 1997.
[44] Malone PM, Fagan NL, Malesker MA; Nelson PJ. Chapter 12. Pharmacy and Therapeutics Committee. In: Drug Information: A Guide for Pharmacists, Fourth Edition (Drug Information (McGraw-Hill)) 4th by Patrick M. Malone, Karen L. Kier, John E. Stanovich, Published by McGraw-Hill Medical; 4 edition (August 17, 2011).
[45] Scott DM, Strand M, Undem T, Anderson G, Clarens A, Liu X. Assessment of pharmacists' delivery of public health services in rural and urban areas in Iowa and North Dakota. Pharm Pract (Granada). 2016; 14 (4): 836.
[46] Bradley F, Seston E, Mannall C, Cutts C. Evolution of the general practice pharmacist's role in England: a longitudinal study. Br J Gen Pract. 2018; 68 (675): e727-e734.
[47] Green BN, Johnson CD. Interprofessional collaboration in research, education, and clinical practice: working together for a better future. J Chiropr Educ. 2015; 29 (1): 1-10.
[48] Bridges DR, Davidson RA, Odegard PS, Maki IV, Tomkowiak J. Interprofessional collaboration: three best practice models of interprofessional education. Med Educ Online. 2011; 16: 10.3402/meo. v16i0. 6035. Published 2011 Apr 8. doi: 10.3402/meo. v16i0. 6035.
[49] Stringer K, Curran V, Asghari S. Pharmacists and family physicians: improving interprofessional collaboration through joint understanding of our competencies. Front Pharmacol. 2013; 4: 151. Published 2013 Dec 5. doi: 10.3389/fphar. 2013. 00151.
[50] Bell C, Daniel S. Pharmacy Leader's Role in Hospital Emergency Preparedness Planning. Hosp Pharm. 2014; 49 (4): 398-404.
[51] Boechler L, Despins R, Holmes J, et al. Advocacy in pharmacy: Changing "what is" into "what should be". Can Pharm J (Ott). 2015; 148 (3): 138-41.
[52] Cooley J, Lee J. Implementing the Pharmacists' Patient Care Process at a Public Pharmacy School. Am J Pharm Educ. 2018; 82 (2): 6301.
[53] Galal SM, Carr-Lopez SM, Gomez S, et al. A collaborative approach to combining service, teaching, and research. Am J Pharm Educ. 2014; 78 (3): 58.
[54] Reidt S, Morgan J, Larson T, Blade MA. The role of a pharmacist on the home care team: a collaborative model between a college of pharmacy and a visiting nurse agency. Home Healthc Nurse. 2013 Feb; 31 (2): 80-7; quiz 88-9. doi: 10.1097/NHH. 0b013e3182778f5f. PubMed PMID: 23314201.
[55] Brown MT, Bussell JK. Medication adherence: WHO cares?. Mayo Clin Proc. 2011; 86 (4): 304-14.
[56] The Pfizer Guide To Careers In Pharmacy. Published by ECOF: HIGH DENSITY MOBILE FILING SYSTEM, 2017-10-17 03: 58: 51 Available From: http://fliphtml5. com/lnym/tjzn/basic/101-150
[57] John C. The changing role of the pharmacist in the 21st century. The Pharmaceutical Journal8 JAN 2018.
[58] Barrett J. Pharmacists Play Key Role in the Future of Health Care. Pharmacy Times JUNE 07, 2017.
[59] Pharmacy Schools Council. The future role of the pharmacist. News 26. 03. 18.
[60] Byne T. What Could the Role of the Pharmacist be in the Future? British Pharmaceutical Students' Association (BPSA) News.
[61] Baker KR. Two Crucial Skills Pharmacists Will Need to Succeed in the Future. DrugTopics Mar 5, 2018.
[62] Warner B. Wanted: young pharmacists to shape the future. NHS England Blog 29 January 2018.
[63] Pharmacy’s Global Transformation Is Pharma’s Opportunity. McCANN Health March 2017.
[64] Guirguis LM, Hughes CA, Makowsky MJ, et al. Development and validation of a survey instrument to measure factors that influence pharmacist adoption of prescribing in Alberta, Canada. Pharm Pract (Granada). 2018; 16 (1): 1068.
[65] Walton SM, Manasse HR. Is It a Good Time to Be a Pharmacist in the US?. Pharmacy (Basel). 2018; 6 (3): 61. Published 2018 Jul 3. doi: 10.3390/pharmacy6030061.
[66] Lau BT, Nurul-Nadiah-Auni AR, Ng SY, Shuen-Wong N. Satisfaction of patients receiving value added-services compared to traditional counter service for prescription refills in Malaysia. Pharm Pract (Granada). 2018; 16 (1): 1075.
[67] Saw PS, Nissen LM, Freeman C, Wong PS, Mak V. Health care consumers' perspectives on pharmacist integration into private general practitioner clinics in Malaysia: a qualitative study. Patient Prefer Adherence. 2015; 9: 467-77. Published 2015 Mar 19. doi: 10.2147/PPA. S73953.
[68] Lee EL, Wong PS, Tan MY, Sheridan J. What role could community pharmacists in Malaysia play in diabetes self-management education and support? The views of individuals with type 2 diabetes. Int J Pharm Pract. 2018 Apr; 26 (2): 138-147. doi: 10.1111/ijpp. 12374. Epub 2017 Jun 2. PubMed PMID: 28574154.
[69] Bourne RS, Baqir W, Onatade R. Pharmacist independent prescribing in secondary care: opportunities and challenges. Int J Clin Pharm. 2016 Feb; 38 (1): 1-6. doi: 10.1007/s11096-015-0226-9. PubMed PMID: 26613738.
[70] Jamshed SQ, Siddiqui MJ, Rana B, Bhagavathula AS. Evaluation of the Involvement of Pharmacists in Diabetes Self-Care: A Review From the Economic Perspective. Front Public Health. 2018; 6: 244. Published 2018 Sep 3. doi: 10.3389/fpubh. 2018. 00244.
[71] ICM Unlimited British Medical Association survey of GPs in England: full report. 2016 https://www.bma.org.uk/-/media/files/pdfs/collective%20voice/influence/key%20negotiations/training%20and%20workforce/bma-survey-of-gps-in-england-final-report. pdf?la=en (accessed 20 Aug 2018).
[72] NHS England General practice forward view. 2016 https://www.england.nhs.uk/wp-content/uploads/2016/04/gpfv. pdf (accessed 20 Aug 2018).
[73] Centre for Pharmacy Postgraduate Education General practice pharmacist training pathway: supporting GP pharmacists of the future. 2016 https://www.cppe.ac.uk/wizard/files/general-practice/gpptp-promo-brochure.pdf (accessed 20 Aug 2018).
[74] Aungst T. Does Nonadherence Really Cost the Health Care System $300 Billion Annually? Pharmacy Times® June 01, 2018.
[75] Haskins D. Community Pharmacist Services: The Missing Link to Optimizing Medication Adherence. Pharmacy Times® September 22, 2017.
[76] Oswald K. Non-adherence: medicine’s weakest link. The Pharmaceutical Journal 8 February 2018.
[77] McDonough RP. Identifying and resolving medication nonadherence. Health Aff. 2014; 33: 1444–1452.
[78] Adams B. Pharmacist-led telephone advice ‘improves medication adherence. The Pharmaceutical Journal 17 February, 2016.
[79] Downs J, Tillman F. Medication Adherence: The Elephant in the Room. US Pharm. 2018; 43 (1) 30-34.
[80] Combs K. Let's Talk: Medication Adherence. Pharmacy Times® July 26, 2017.
[81] Drovandi A, Robertson K, Tucker M, Robinson N, Perks S, Kairuz T. A systematic review of clinical pharmacist interventions in paediatric hospital patients. Eur J Pediatr. 2018 Jun 19. doi: 10.1007/s00431-018-3187-x. [Epub ahead of print] Review. PubMed PMID: 29915870.
[82] Tripathi S, Crabtree HM, Fryer KR, Graner KK, Arteaga GM. Impact of Clinical Pharmacist on the Pediatric Intensive Care Practice: An 11-Year Tertiary Center Experience. J Pediatr Pharmacol Ther. 2015; 20 (4): 290-8.
[83] Kennedy MJ, Phan H, Benavides S, Potts A, Sorensen S. The role of the pediatric pharmacist in personalized medicine and clinical pharmacogenomics for children: pediatric pharmacogenomics working group. J Pediatr Pharmacol Ther. 2011; 16 (2): 118-22.
[84] Abrogoua DP, Békégnran CP, Gro BM, Doffou E, Folquet MA. Assessment of a Clinical Pharmacy Activity in a Pediatric Inpatient Department in Cote D'ivoire. J Basic Clin Pharm. 2016; 8 (1): 15-19.
[85] Wachman EM, Werler MM. Pharmacologic Treatment for Neonatal Abstinence Syndrome: Which Medication Is Best? JAMA Pediatr. Published online January 22, 2019. doi: 10.1001/jamapediatrics. 2018. 5029.
[86] Perrin JH. Pediatrician and Compounding Pharmacist: A Dangerous Liaison. Arch Pediatr Adolesc Med. 1996; 150 (2): 224–226. doi: 10.1001/archpedi. 1996. 02170270106020.
[87] Lea S. Eiland, Kim Benner, Karl F. Gumpper, Melissa K. Heigham, Rachel Meyers, Katherine Pham, Amy L. Potts; ASHP–PPAG Guidelines for Providing Pediatric Pharmacy Services in Hospitals and Health Systems, American Journal of Health-System Pharmacy, Volume 75, Issue 15, 1 August 2018, Pages 1151–1165, https://doi.org/10.2146/ajhp170827.
[88] Teka NT, Baye AM. Counseling practice of community pharmacists for diabetes mellitus patients in Addis Ababa, Ethiopia. BMC Res Notes. 2018; 11 (1): 700. Published 2018 Oct 4. doi: 10.1186/s13104-018-3807-6.
[89] Jeong S, Lee M, Ji E. Effect of pharmaceutical care interventions on glycemic control in patients with diabetes: a systematic review and meta-analysis. Ther Clin Risk Manag. 2018; 14: 1813-1829. Published 2018 Sep 28. doi: 10.2147/TCRM. S169748.
[90] Bukhsh A, Nawaz MS, Ahmed HS, Khan TM. A randomized controlled study to evaluate the effect of pharmacist-led educational intervention on glycemic control, self-care activities and disease knowledge among type 2 diabetes patients: A consort compliant study protocol. Medicine (Baltimore). 2018; 97 (12): e9847.
[91] Pousinho S, Morgado M, Falcão A, Alves G. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials. J Manag Care Spec Pharm. 2016 May; 22 (5): 493-515. doi: 10.18553/jmcp.2016.22.5.493.
[92] Santschi V, Chiolero A, Burnand B, et al. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 2011; 171: 1441–53. 10. 1001/archinternmed. 2011. 399.
[93] Lowrie R, Lloyd SM, McConnachie A, Morrison J. A cluster randomised controlled trial of a pharmacist-led collaborative intervention to improve statin prescribing and attainment of cholesterol targets in primary care. PLoS One. 2014; 9 (11): e113370. Published 2014 Nov 18. doi: 10.1371/journal. pone. 0113370.
[94] Cheng JW. Current perspectives on the role of the pharmacist in heart failure management. Integr Pharm Res Pract. 2018; 7: 1-11. Published 2018 Mar 9. doi: 10.2147/IPRP. S137882.
[95] Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel). 2016; 4 (3): 36. Published 2016 Jun 29. doi: 10.3390/healthcare4030036.
[96] Digiantonio N, Lund J, Bastow S. Impact of a Pharmacy-Led Medication Reconciliation Program. P T. 2018; 43 (2): 105-110.
[97] Petrov K, Varadarajan R, Healy M, Darvish E, Cowden C. Improving Medication History at Admission Utilizing Pharmacy Students and Technicians: A Pharmacy-Driven Improvement Initiative. P T. 2018; 43 (11): 676-684.
[98] Mekonnen AB, McLachlan AJ, Brien JE, Mekonnen D, Abay Z. Medication reconciliation as a medication safety initiative in Ethiopia: a study protocol. BMJ Open. 2016; 6 (11): e012322. Published 2016 Nov 24. doi: 10.1136/bmjopen-2016-012322.
[99] Procopio GL, Faley B, Wynd MA, Finefrock D, Kobayashi M, Feldman J. Pharmacy collected medication histories in an observation unit. SAGE Open Med. 2015; 3: 2050312115598872. Published 2015 Aug 12. doi: 10.1177/2050312115598872.
[100] Smith L, Mosley J, Lott S, et al. Impact of pharmacy-led medication reconciliation on medication errors during transition in the hospital setting. Pharm Pract (Granada). 2015; 13 (4): 634.
[101] Gupta V, Williams E. Establishing a New Ambulatory Care Practice Site as a Pharmacy Practice Faculty. Pharmacy (Basel). 2018; 6 (4): 111. Published 2018 Oct 11. doi: 10.3390/pharmacy6040111.
Cite This Article
  • APA Style

    A. K. Mohiuddin. (2019). The Excellence of Pharmacy Service: Past, Present and Future. International Journal of Clinical and Developmental Anatomy, 5(2), 11-32. https://doi.org/10.11648/j.ijcda.20190502.12

    Copy | Download

    ACS Style

    A. K. Mohiuddin. The Excellence of Pharmacy Service: Past, Present and Future. Int. J. Clin. Dev. Anat. 2019, 5(2), 11-32. doi: 10.11648/j.ijcda.20190502.12

    Copy | Download

    AMA Style

    A. K. Mohiuddin. The Excellence of Pharmacy Service: Past, Present and Future. Int J Clin Dev Anat. 2019;5(2):11-32. doi: 10.11648/j.ijcda.20190502.12

    Copy | Download

  • @article{10.11648/j.ijcda.20190502.12,
      author = {A. K. Mohiuddin},
      title = {The Excellence of Pharmacy Service: Past, Present and Future},
      journal = {International Journal of Clinical and Developmental Anatomy},
      volume = {5},
      number = {2},
      pages = {11-32},
      doi = {10.11648/j.ijcda.20190502.12},
      url = {https://doi.org/10.11648/j.ijcda.20190502.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcda.20190502.12},
      abstract = {Pharmacy education continues to evolve to better prepare pharmacists for their roles and responsibilities in an increasingly complex health care environment with advanced patient health needs. Another important factor is the pharmacists themselves. Over the past 50 years, the role of pharmacists has evolved along with the health care needs of our population. In addition to dispensing medications and ensuring patient safety, today’s pharmacists are taking a larger role as medical counselors, educators and advocates. They are integral part of the health care team, and are among the most trusted and accessible health care professionals. This accessibility allows them to perform more patient care activities, including counseling, medication management, and preventive care screenings. Beyond the care provided to individual patients, pharmacists have expanded their reach to influence the public health of communities. A pharmacist is uniquely positioned to provide disease state management through appropriate medication therapy management that has been demonstrated to improve patient outcomes and decrease overall health care costs. This role is more important than ever as the environment is demanding new practice and payment models that are required to further optimize care and outcomes while addressing the unsustainable increases in health care costs. All people who take medications are at risk of actual or potential drug therapy problems. These problems are a significant source of morbidity and mortality when left undetected and unresolved and drive huge costs across the health system. As drug therapy experts, pharmacists provide drug therapy management services built around a partnership between the pharmacist, the patient (or his or her caregiver), physicians and other members of a patient’s health care team.},
     year = {2019}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - The Excellence of Pharmacy Service: Past, Present and Future
    AU  - A. K. Mohiuddin
    Y1  - 2019/12/25
    PY  - 2019
    N1  - https://doi.org/10.11648/j.ijcda.20190502.12
    DO  - 10.11648/j.ijcda.20190502.12
    T2  - International Journal of Clinical and Developmental Anatomy
    JF  - International Journal of Clinical and Developmental Anatomy
    JO  - International Journal of Clinical and Developmental Anatomy
    SP  - 11
    EP  - 32
    PB  - Science Publishing Group
    SN  - 2469-8008
    UR  - https://doi.org/10.11648/j.ijcda.20190502.12
    AB  - Pharmacy education continues to evolve to better prepare pharmacists for their roles and responsibilities in an increasingly complex health care environment with advanced patient health needs. Another important factor is the pharmacists themselves. Over the past 50 years, the role of pharmacists has evolved along with the health care needs of our population. In addition to dispensing medications and ensuring patient safety, today’s pharmacists are taking a larger role as medical counselors, educators and advocates. They are integral part of the health care team, and are among the most trusted and accessible health care professionals. This accessibility allows them to perform more patient care activities, including counseling, medication management, and preventive care screenings. Beyond the care provided to individual patients, pharmacists have expanded their reach to influence the public health of communities. A pharmacist is uniquely positioned to provide disease state management through appropriate medication therapy management that has been demonstrated to improve patient outcomes and decrease overall health care costs. This role is more important than ever as the environment is demanding new practice and payment models that are required to further optimize care and outcomes while addressing the unsustainable increases in health care costs. All people who take medications are at risk of actual or potential drug therapy problems. These problems are a significant source of morbidity and mortality when left undetected and unresolved and drive huge costs across the health system. As drug therapy experts, pharmacists provide drug therapy management services built around a partnership between the pharmacist, the patient (or his or her caregiver), physicians and other members of a patient’s health care team.
    VL  - 5
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Department of Pharmacy, World University of Bangladesh, Bangladesh, Dhaka, Bangladesh

  • Sections